247 related articles for article (PubMed ID: 5313711)
1. [TSH and the "long-acting thyroid stimulator" (LATS) in patients with compensated hyperthyroidism].
zur Mühlen A von ; Hesch RD; von Lilienfeld H; Emrich D
Acta Endocrinol Suppl (Copenh); 1971; 152():86. PubMed ID: 5313711
[No Abstract] [Full Text] [Related]
2. Clinical significance of LATS and TSH in the blood.
Lemarchand-Béraud T; Griessen M; Scazziga BR
Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
[No Abstract] [Full Text] [Related]
3. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
Lamberg BA; Gordin A
Nord Med; 1968 Dec; 80(49):1651-7. PubMed ID: 5757398
[No Abstract] [Full Text] [Related]
4. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
Gautier E; Juillard E; Lemarchand-Béraud T
Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
[No Abstract] [Full Text] [Related]
5. [The long-acting thyroid stimulator (LATS) in untreated and I-131 treated hyperthyreoses, following total thyroidectomy, as well as its relation to thyroid antibodies].
Ziemke A; Weisbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W
Klin Wochenschr; 1968 Oct; 46(19):1025-7. PubMed ID: 5727481
[No Abstract] [Full Text] [Related]
6. Long-acting thyroid stimulator (LATS) in hyperthyroidism and exophthalmos.
Friis T
Dan Med Bull; 1969 Nov; 16(10):294-304. PubMed ID: 5392781
[No Abstract] [Full Text] [Related]
7. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(4):121-30. PubMed ID: 5757238
[No Abstract] [Full Text] [Related]
8. [Pitfalls in the biological demonstration of the "long acting thyroid stimulator" (LATS)].
Mertz DP; Stelzer M
Schweiz Med Wochenschr; 1968 Sep; 98(38):1471-5. PubMed ID: 5680881
[No Abstract] [Full Text] [Related]
9. [Fluctuations of the long-acting thyroid stimulator (LATS) concentration in the blood and its significance in hyperthyroidism].
Noguchi A; Kurihara H; Ozeki Y; Sato S
Nihon Rinsho; 1967 Oct; 25(8):1723-32. PubMed ID: 5626106
[No Abstract] [Full Text] [Related]
10. Plasma thyrotropin (TSH) and long-acting thyroid stimulator (LATS) in patients treated for thyroid carcinoma.
Valenta L; Lemarchand-Béraud T; Vannotti A
Eur J Cancer (1965); 1970 Apr; 6(2):139-43. PubMed ID: 5450187
[No Abstract] [Full Text] [Related]
11. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
Busnardo B; Accordi F; Debiasi S
Acta Isot (Padova); 1968 Oct; 8(2):165-79. PubMed ID: 5761578
[No Abstract] [Full Text] [Related]
12. The pathogenesis of thyrotoxicosis the discovery of LATS.
Adams DD
N Z Med J; 1975 Jan; 81(531):15-7. PubMed ID: 1055308
[No Abstract] [Full Text] [Related]
13. Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.
Alford FP; Larkins RG; Martin FI
Aust N Z J Med; 1971 Nov; 1(4):339-45. PubMed ID: 5292990
[No Abstract] [Full Text] [Related]
14. [Long-acting thyroid stimulator (LATS) as the cause of hyperthyroidism. Comparison of different TSH and LATS preparations].
Seif F
Dtsch Med Wochenschr; 1967 Jan; 92(4):147-52. PubMed ID: 6016320
[No Abstract] [Full Text] [Related]
15. [Serum thyrotropic hormone (T.S.H.) and the long acting stimulator substance (L.A.T.S.) in hyperthyroidism. Preliminary communication].
Bonnyns M
Rev Fr Etud Clin Biol; 1967 Jan; 12(1):77-9. PubMed ID: 6052803
[No Abstract] [Full Text] [Related]
16. The value of IgG separation for the detection of LATS in human serum.
Bonnyns M; Vanhaelst L
Clin Exp Immunol; 1969 May; 4(5):597-601. PubMed ID: 5815122
[TBL] [Abstract][Full Text] [Related]
17. [Effect of iodine administration on the thyrotropic hormone and long-acting thyroid stimulator level in the plasma].
Földes J; Krasznai I; Piroska E; Gesztesi E; Takács I
Endokrinologie; 1967; 52(1):80-7. PubMed ID: 4171706
[No Abstract] [Full Text] [Related]
18. [Determination of thyrotropic hormone and long acting thyroid stimulator by the McKenzie technique. Critical study of the method].
Bonnyns M
Rev Fr Etud Clin Biol; 1968 Nov; 13(9):845-52. PubMed ID: 5709509
[No Abstract] [Full Text] [Related]
19. Changes in LATS and other thyoid autoantibody levels with therapy.
Kilpatrick JA
N Z Med J; 1974 Dec; 80(529):495-6. PubMed ID: 4532201
[No Abstract] [Full Text] [Related]
20. Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.
Chopra IJ; Solomon DH; Johnson DE; Chopra U; Fischer DA
J Clin Endocrinol Metab; 1970 Apr; 30(4):524-8. PubMed ID: 5435290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
